icon- folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
February 13-16, 2017, Seattle WA
 Back grey_arrow_rt.gif
 
 
 
Long-Term Efficacy of Dolutegravir 50 mg BID in INI-Resistant Failing HIV-1 Subjects
 
 
 

0215171

0215172

0215173

0215174

0215175

0215176

0215177

0215178

0215179

02151710